Sunday, September 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 11, 2026

Aduro Clean Technologies gibt Ausgabepreis für ein garantiertes öffentliches Emissionsangebot in Höhe von 15,64 Millionen US-Dollar sowie eine gleichzeitige Privatplatzierung von bis zu 7,17 Millionen US-Dollar bekannt

View original at globenewswire.com
Aduro Clean Technologies gibt Ausgabepreis für ein garantiertes öffentliches Emissionsangebot in Höhe von 15,64 Millionen US-Dollar sowie eine gleichzeitige Privatplatzierung von bis zu 7,17 Millionen US-Dollar bekannt LONDON, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Aduro's Hydrochemolytic™ technology uses water as the primary active ingredient in a chemical platform that operates at relatively low temperatures and costs.

    60% confidence
  • The company anticipates that certain insiders may participate in the LIFE offering, constituting a 'related party transaction' under MI 61-101, but expects to rely on exemptions from formal valuation and minority shareholder approval requirements as insider participation is not expected to exceed 25% of the company's market capitalization.

    60% confidence
  • The public offering is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions, including listing of offered shares on the TSX and Nasdaq and receipt of all required TSX and Nasdaq approvals.

    60% confidence
  • The public offering is not conditional on completion of the LIFE offering, and the LIFE offering is not conditional on completion of the public offering.

    60% confidence
  • The company intends to rely on the exemption under Section 602.1 of the TSX Company Manual, which provides that the TSX does not apply its standards to certain transactions involving eligible issuers listed on a recognized exchange.

    60% confidence
  • Aduro intends to use net proceeds from the offering for planning, development, and construction of the world's first industrial-scale FOAK demonstration facility, ongoing R&D expenses, and remaining amounts for general corporate purposes and working capital.

    60% confidence
  • The LIFE offering is expected to close on or about the closing date or another date determined by the company, but no later than 45 days after the date of this press release. The LIFE offering may close in one or more tranches.

    60% confidence

Data points we hold from this source

Aduro Clean Technologies Inc. · gross proceeds life offering7169810 USD
Aduro Clean Technologies Inc. · gross proceeds public offering15635404 USD
Aduro Clean Technologies Inc. · shares offered public1028645 shares
Aduro Clean Technologies Inc. · shares offered life private placement471698 shares
Aduro Clean Technologies Inc. · offer price usd15.20 USD_per_share
Aduro Clean Technologies Inc. · offer price cad21.20 CAD_per_share
Aduro Clean Technologies Inc. · gross proceeds total combined22805214 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com
Aduro Clean Technologies gibt Ausgabepreis für ein garantiertes öffentliches Emissionsangebot in Höhe von 15,64 Millionen US-Dollar sowie eine gleichzeitige Privatplatzierung von bis zu 7,17 Millionen US-Dollar bekannt — Source | Via News | Finance Via News